Efficacy and Tolerability of Deucravacitinib in the Management of Palmoplantar Pustulosis
Clinical trial NCT07000630 · TERMINATED
Trial details
- NCT number
- NCT07000630
- Sponsor
- Peking University First Hospital
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-20
- Primary completion
- 2025-11-30
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.